Characteristics of PRIMPOL knockout А549 cell response to genоtoxic stress
- Autores: Gromova A.1,2, Boldinova E.1,2, Kim D.3,4, Chuprov-netochin R.5, Leonov S.5,6, Pustovalova M.5, Zharkov D.3,4, Makarova A.1,2
-
Afiliações:
- Institute of Molecular Genetics, National Research Center “Kurchatov Institute”
- Institute of Gene Biology, Russian Academy of Sciences
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences
- Novosibirsk State University
- Moscow Institute of Physics and Technology
- Institute of Cell Biophysics of the Russian Academy of Sciences
- Edição: Volume 88, Nº 11 (2023)
- Páginas: 2340-2352
- Seção: Regular articles
- URL: https://journals.rcsi.science/0320-9725/article/view/233528
- DOI: https://doi.org/10.31857/S0320972523110222
- EDN: https://elibrary.ru/MMJMCO
- ID: 233528
Citar
Resumo
Palavras-chave
Sobre autores
A. Gromova
Institute of Molecular Genetics, National Research Center “Kurchatov Institute”;Institute of Gene Biology, Russian Academy of Sciences123182 Moscow, Russia;119334 Moscow, Russia
E. Boldinova
Institute of Molecular Genetics, National Research Center “Kurchatov Institute”;Institute of Gene Biology, Russian Academy of Sciences123182 Moscow, Russia;119334 Moscow, Russia
D. Kim
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences;Novosibirsk State University630090 Novosibirsk, Russia;630090 Novosibirsk, Russia
R. Chuprov-netochin
Moscow Institute of Physics and Technology141700 Dolgoprudny, Moscow Region, Russia
S. Leonov
Moscow Institute of Physics and Technology;Institute of Cell Biophysics of the Russian Academy of Sciences141700 Dolgoprudny, Moscow Region, Russia;142290 Pushchino, Russia
M. Pustovalova
Moscow Institute of Physics and Technology141700 Dolgoprudny, Moscow Region, Russia
D. Zharkov
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences;Novosibirsk State University
Email: dzharkov@niboch.nsc.ru
630090 Novosibirsk, Russia;630090 Novosibirsk, Russia
A. Makarova
Institute of Molecular Genetics, National Research Center “Kurchatov Institute”;Institute of Gene Biology, Russian Academy of Sciences
Email: amakarova-img@yandex.ru
123182 Moscow, Russia;119334 Moscow, Russia
Bibliografia
- Игнатов А. В., Бондаренко К. А., Макарова А. В. (2017) Необъемные повреждения ДНК у человека: пути образования, репарации и репликации, Acta Naturae, 9, 13-28, doi: 10.32607/20758251-2017-9-3-12-26.
- Vaisman, A., and Woodgate, R. (2017) Translesion DNA polymerases in eukaryotes: what makes them tick? Crit. Rev. Biochem. Mol. Biol., 52, 274-303, doi: 10.1080/10409238.2017.1291576.
- Jain, R., Aggarwal, A. K., and Rechkoblit, O. (2018) Eukaryotic DNA polymerases, Curr. Opin. Struct. Biol., 53, 77-87, doi: 10.1016/j.sbi.2018.06.003.
- Dash, R. C., and Hadden, K. (2021) Protein-protein interactions in translesion synthesis, Molecules, 26, 5544, doi: 10.3390/molecules26185544.
- García-Gómez, S., Reyes, A., Martínez-Jiménez, M. I., Chocrón, S., Mourón, S., et al. (2013) PrimPol, an archaic primase/polymerase operating in human cells, Mol. Cell, 52, 541-553, doi: 10.1016/j.molcel.2013.09.025.
- Bianchi, J., Rudd, S. G., Jozwiakowski, S. K., Bailey, L. J., Soura, V., et al. (2013) Primpol bypasses UV photoproducts during eukaryotic chromosomal DNA replication, Mol. Cell, 52, 566-573, doi: 10.1016/j.molcel.2013.10.035.
- Wan, L., Lou, J., Xia, Y., Su, B., Liu, T., et al. (2013) HPrimpol1/CCDC111 is a human DNA primase-polymerase required for the maintenance of genome integrity, EMBO Rep., 14, 1104-1112, doi: 10.1038/embor.2013.159.
- Iyer, L. M., Koonin, E. V., Leipe, D. D., and Aravind, L. (2005) Origin and evolution of the archaeo-eukaryotic primase superfamily and related palm-domain proteins: Structural insights and new members, Nucleic Acids Res., 33, 3875-3896, doi: 10.1093/nar/gki702.
- González-Acosta, D., Blanco-Romero, E., Ubieto-Capella, P., Mutreja, K., Míguez, S., et al. (2021) PrimPol-mediated repriming facilitates replication traverse of DNA interstrand crosslinks, EMBO J., 40, e106355, doi: 10.15252/embj.2020106355.
- Piberger, A. L., Bowry, A., Kelly, R., Walker, A. K., Gonzalez, D., Bailey, L. J., et al. (2020) PrimPol-dependent single-stranded gap formation mediates homologous recombination at bulky DNA adducts, Nat. Commun., 11, 5863, doi: 10.1038/s41467-020-19570-7.
- Butler, T. J., Estep, K. N., Sommers, J. A., Maul, R. W., Moore, A. Z., Bandinelli, S., et al. (2020) Mitochondrial genetic variation is enriched in G-quadruplex regions that stall DNA synthesis in vitro, Hum. Mol. Genet., 29, 1292-1309, doi: 10.1093/hmg/ddaa043.
- Šviković, S., Crisp, A., Tan-Wong, S. M., Guilliam, T. A., Doherty, A. J., Proudfoot, N. J., Guilbaud, G., and Sale, J. E. (2019) R-loop formation during S phase is restricted by PrimPol-mediated repriming, EMBO J., 38, e99793, doi: 10.15252/embj.201899793.
- Quinet, A., Tirman, S., Jackson, J., Šviković, S., Lemaçon, D., et al. (2019) PRIMPOL-mediated adaptive response suppresses replication fork reversal in BRCA-deficient cells, Mol. Cell, 77, 461-474.e9, doi: 10.1016/j.molcel.2019.10.008.
- Torregrosa-Muñumer, R., Forslund, J., Goffart, S., Pfeiffer, A., Stojkovic, G., et al. (2017) PrimPol is required for replication reinitiation after mtDNA damage, Proc. Natl. Acad. Sci. USA, 114, 11398-11403, doi: 10.1073/pnas.1705367114.
- Kobayashi, K., Guilliam, T. A., Tsuda, M., Yamamoto, J., Bailey, L. J., Iwai, S., Takeda, S., Doherty, A. J., and Hirota, K. (2016) Repriming by PrimPol is critical for DNA replication restart downstream of lesions and chain-terminating nucleosides, Cell Cycle, 15, 1997-2008, doi: 10.1080/15384101.2016.1191711.
- Taglialatela, A., Leuzzi, G., Sannino, V., Cuella-Martin, R., Huang, J. W., et al. (2021) REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps, Mol. Cell, 81, 4008-4025.e7, doi: 10.1016/j.molcel.2021.08.016.
- Makarova, A. V., Boldinova, E. O., Belousova, E. A., and Lavrik, O. I. (2018) In vitro lesion bypass by human PrimPol, DNA Rep., 70, 18-24, doi: 10.1016/j.dnarep.2018.07.009.
- Guilliam, T. A., Jozwiakowski, S. K., Ehlinger, A., Barnes, R. P., Rudd, S. G., et al. (2015) Human PrimPol is a highly error-prone polymerase regulated by single-stranded DNA binding proteins, Nucleic Acids Res., 43, 1056-1068, doi: 10.1093/nar/gku1321.
- Zafar, M. K., Ketkar, A., Lodeiro, M. F., Cameron, C. E., and Eoff, R. L. (2014) Kinetic analysis of human PrimPol DNA polymerase activity reveals a generally error-prone enzyme capable of accurately bypassing 7,8-dihydro-8-oxo-2′-deoxyguanosine, Biochemistry, 53, 6584-6594, doi: 10.1021/bi501024u.
- Boldinova, E. O., Yudkina, A. V., Shilkin, E. S., Gagarinskaya, D. I., Baranovskiy, A. G., et al. (2021) Translesion activity of PrimPol on DNA with cisplatin and DNA-protein cross-links, Sci. Rep., 11, 17588, doi: 10.1038/s41598-021-96692-y.
- Mourón, S., Rodriguez-Acebes, S., Martínez-Jiménez, M. I., García-Gómez, S., Chocrón, S., Blanco, L., and Méndez, J. (2013) Repriming of DNA synthesis at stalled replication forks by human PrimPol, Nat. Struct. Mol. Biol., 20, 1383-1389, doi: 10.1038/nsmb.2719.
- Bailey, L. J., Bianchi, J., Hégarat, N., Hochegger, H., and Doherty, A. J. (2016) PrimPol-deficient cells exhibit a pronounced G2 checkpoint response following UV damage, Cell Cycle, 15, 908-918, doi: 10.1080/15384101.2015.1128597.
- Schiavone, D., Jozwiakowski, S. K., Romanello, M., Guilbaud, G., Guilliam, T. A., et al. (2016) PrimPol is required for replicative tolerance of G quadruplexes in vertebrate cells, Mol. Cell, 61, 161-169, doi: 10.1016/j.molcel.2015.10.038.
- Bailey, L. J., Bianchi, J., and Doherty, A. J. (2019) PrimPol is required for the maintenance of efficient nuclear and mitochondrial DNA replication in human cells, Nucleic Acids Res., 47, 4026-4038, doi: 10.1093/nar/gkz056.
- Duong, V. N., Zhou, L., Martínez-Jiménez, M. I., He, L., Cosme, M., et al. (2020) Identifying the role of PrimPol in TDF-induced toxicity and implications of its loss of function mutation in an HIV+ patient, Sci. Rep., 10, 9343, doi: 10.1038/s41598-020-66153-z.
- Jamieson, E. R., and Lippard, S. J. (1999) Structure, recognition, and processing of cisplatin - DNA adducts, Chem. Rev., 99, 2467-2498, doi: 10.1021/cr980421n.
- Natile, G., and Cannito, F. (2009) Platinum drugs, nucleotides and DNA: the role of interligand interactions, in Metal Complex-DNA Interactions, pp. 135-173, doi: 10.1002/9781444312089.ch5.
- Hay, J., Shahzeidi, S., and Laurent, G. (1991) Mechanisms of bleomycin-induced lung damage, Arch. Toxicol., 65, 81-94, doi: 10.1007/BF02034932.
- Díaz-Talavera, A., Calvo, P. A., González-Acosta, D., Díaz, M., Sastre-Moreno, G., et al. (2019) A cancer-associated point mutation disables the steric gate of human PrimPol, Sci. Rep., 9, 1121, doi: 10.1038/s41598-018-37439-0.
- Kang, Z., Fu, P., Alcivar, A. L., Fu, H., Redon, C., et al. (2021) BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage, Nat. Commun., 12, 5966, doi: 10.1038/s41467-021-26227-6.
- Pilzecker, B., Buoninfante, O. A., Pritchard, C., Blomberg, O. S., Huijbers, I. J., Van Den Berk, P. C. M., and Jacobs, H. (2016) PrimPol prevents APOBEC/AID family mediated DNA mutagenesis, Nucleic Acids Res., 44, 4734-4744, doi: 10.1093/nar/gkw123.
- Guilliam, T. A., Bailey, L. J., Brissett, N. C., and Doherty, A. J. (2016) PolDIP2 interacts with human PrimPol and enhances its DNA polymerase activities, Nucleic Acids Res., 44, 3317-3329, doi: 10.1093/nar/gkw175.
- Keen, B. A., Bailey, L. J., Jozwiakowski, S. K., and Doherty, A. J. (2014) Human PrimPol mutation associated with high myopia has a DNA replication defect, Nucleic Acids Res., 42, 12102-12111, doi: 10.1093/nar/gku879.
- Liu, J., Lee, W., Jiang, Z., Chen, Z., Jhunjhunwala, S., et al. (2012) Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events, Genome Res., 22, 2315-2327, doi: 10.1101/gr.140988.112.
- Vaisman, A., Masutani, C., Hanaoka, F., and Chaney, S. G. (2000) Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta, Biochemistry, 39, 4575-4580, doi: 10.1021/bi000130k.
- Shen, M., Qi, R., Ren, J., Lv, D., and Yang, H. (2022) Characterization with KRAS mutant is a critical determinant in immunotherapy and other multiple therapies for non-small cell lung cancer, Front. Oncol., 11, 780655, doi: 10.3389/fonc.2021.780655.
- Yoon, Y. K., Kim, H. P., Han, S. W., Oh, D. Y., Im, S. A., et al. (2010) KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: Implication for combinatorial approach, Mol. Carcinog., 49, 353-362, doi: 10.1002/mc.20607.
- Garassino, M. C., Marabese, M., Rusconi, P., Rulli, E., Martelli, O., et al. (2011) Different types of K-Ras mutations could affect drug sensitivity and tumour behaviour in non-small-cell lung cancer, Ann. Oncol., 22, 235-237, doi: 10.2959/logo.2002.13.2.109.
- Shepherd, F. A., Domerg, C., Hainaut, P., Jänne, P. A., Pignon, J. P., et al. (2013) Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy, J. Clin. Oncol., 31, 2173-2181, doi: 10.1200/JCO.2012.48.1390.
- Sarin, N., Engel, F., Kalayda, G. V., Mannewitz, M., Cinatl, J., et al. (2017) Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest, PLoS One, 12, e0181081, doi: 10.1371/journal.pone.0181081.
- Gao, Y., Dorn, P., Liu, S., Deng, H., Hall, S. R. R., et al. (2019) Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment, Cancer Cell Int., 19, 317, doi: 10.1186/s12935-019-1037-1.
- Ray, R., Al Khashali, H., Haddad, B., Wareham, J., Coleman, K. L., et al. (2022) Regulation of cisplatin resistance in lung cancer cells by nicotine, BDNF, and a β-adrenergic receptor blocker, Int. J. Mol. Sci., 23, 12829, doi: 10.3390/ijms232112829.